We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Brain Activity Patterns Could Predict Pain Sensitivity

Siobhan Schabrun, Health Sciences professor, and David Seminowicz, Schulich Medicine & Dentistry professor with a participant having a brain scan.
Credit: Christopher Kindratsky / Western Communications.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 3 minutes

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience Research Australia (NeuRA) uncovered how specific patterns in brain activity can predict an individual’s sensitivity to pain, expanding opportunities for improved pain management strategies.  


The new study was published Jan. 27 in JAMA Neurology. It found the combination of two biomarkers in the brain – corticomotor excitability (CME), excitability in the region of the brain that controls movement, and peak alpha frequency (PAF), a neural marker associated with cognitive performance – can accurately and reliably distinguish high- and low-pain sensitive individuals during prolonged pain.


“The burden of chronic pain is massive. Having objective biomarkers would greatly assist with decision making in the diagnosis, prevention and treatment of chronic pain,” said senior author and Schulich School of Medicine & Dentistry professor David Seminowicz, who started the study while he was a professor at UMSOD.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

For people who suffer from prolonged or chronic pain, this means they could be more effectively treated according to their level of pain sensitivity. 


According to recent data from the Global Burden of Disease study, approximately 1.7 billion people around the world live with musculoskeletal conditions, typically characterized by persistent pain, including pain in muscles, bones, joints, ligaments and tendons. Living with prolonged pain can be debilitating and affect a person’s ability to work or socialize. Currently, there is a lack of effective treatments for chronic pain and a gap in understanding the transition from acute to chronic pain. 


“For the first time we have something that looks like it could predict pain outcome for people,” said Siobhan Schabrun, co-author and professor at Western’s School of Physical Therapy in the Faculty of Health Sciences.


The researchers looked specifically at jaw pain typically attributed to problems with the joint or muscles in the jaw, also known as temporomandibular disorders. 


The study involved 150 participants in Australia, aged 18 to 44. PAF, the brain biomarker associated with cognitive performance, was measured using electroencephalography (EEG) recording, which records electrical activity in the brain using electrodes. CME, the biomarker related to excitability, was measured through transcranial magnetic stimulation, where nerve cells in the brain are stimulated using magnetic fields. 


This research was a collaborative effort between Nahian Chowdhury, research fellow at NeuRA, who led the data collection; a statistical team led by University of Maryland School of Medicine postdoctoral fellow Chuan Bi and professor Shuo Chen; and principal investigator of the UMSOD site, assistant professor Joyce Teixeira Da Silva. 

Biomarkers could help predict future pain 

“Our results suggest individuals who have slow PAF prior to a prolonged pain episode and reduced CME shortly after the onset of a prolonged pain episode are more likely to experience higher pain days or weeks later,” Seminowicz said. 


Additional findings from complementary studies show individuals with low levels of CME during the acute stages of low back pain were more likely to develop chronic pain after six months.  


The new research also shows potential to measure PAF and CME in pre-operative and post-injury settings to identify whether a patient has high or low pain sensitivity.  


Based on previous literature that found higher acute pain can predict the development of chronic pain, the researchers suggest these biomarkers, PAF and CME, could potentially be used to gauge a person’s likelihood of developing chronic pain after an experience with acute pain.   

‘A major leap forward’ 

“This study represents a major leap forward in the field of pain science. A biomarker that can predict pain sensitivity with 88 per cent accuracy has the potential to transform the treatment and prevention of pain in future,” said Schabrun, who is also William and Lynne Gray Endowed Research Chair in Mobility and Activity at St. Joseph’s Health Care London. 


Backed by the high rates of accuracy, reproducibility and reliability of their study, the researchers are now working to validate the biomarker in clinical populations to explore clinical translation, including predicting the transition from acute to chronic clinical pain. 


“This would allow us to target treatments toward people with acute pain who are likely to transition to chronic pain,” said Schabrun. “If these brain biomarkers can predict that occurrence in future, we hope to be able to interfere with the transition to chronic pain to provide better patient outcomes.”


Reference: Chowdhury NS, Bi C, Furman AJ, et al. Predicting individual pain sensitivity using a novel cortical biomarker signature. JAMA Neurol. 2025. doi: 10.1001/jamaneurol.2024.4857


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.